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MATERIALS AND METHODS: Cycles of IVF conducted between
January 2010 and January 2013 at Maria Fertility Hospital in which
late cleaved and rescue ICSI embryos were reviewed. The patients
were divided in five groups: group A (n¼17), Frozen-thawed late cleaved
embryo transfer cycles, group B (n¼5), Frozen-thawed rescue ICSI em-
bryo transfer cycles in failed conventional insemination (CI), group C
(n¼9), Frozen-thawed rescue ICSI embryo transfer cycles in additional
IVM, group D (n¼ 16), Fresh rescue ICSI embryo transfer cycles in
failed CI, group E (n¼66), Fresh rescue ICSI embryo transfer cycles in
additional IVM. Cryopreserved embryos were transferred to patients
either in natural cycle or in a hormonal cycle. Late cleaved and rescue
ICSI embryos were frozen on day 4 using vitrification. Late cleaved
and rescue ICSI embryos were thawed on 1 day before ET. Fresh embryo
transfer was performed on day 3.
RESULTS: There were no differences in patient age, mean number of
transferred embryos and endometrial thickness. Otherwise, pregnancy rates
were improved in froze-thawed late cleaved embryo transfer (36.8%). In
rescue ICSI cycle, the pregnancy rates were significantly higher in group B
and C (60.0% and 22.2%) than in group D and E (6% and 3%).
CONCLUSION: Low pregnancy potentials of the late cleaved and
rescue ICSI embryos can be overcome by frozen-thawed procedure. It
seems that the frozen-thawed procedure of the late cleaved and rescue
ICSI embryos enabled more appropriate synchronization between embry-
onic and endometrial development. Therefore the late cleaved and rescue
ICSI embryo cryopreservation may be an effective alternative to fresh
embryo transfer.
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STEM CELLS. I. I. Katkov,a,b V. F. Bolyukh,a,c Y. Liu,b D. Wu,b
E. Y. Snyder,b S. Agarwal.d aCELLTRONIX, San Diego, CA; bStem Cell
Core, Sanford-BurnhamMedical Research Intsitute, La Jolla, CA; cElectrical
Engineering, National Technical University ‘‘KhPI’’, Kharkov, Kharkov Re-
gion, Ukraine; dReproductive Medicine, UCSD School of Medicine, Univer-
sity of California at San Diego (UCSD), La Jolla, CA.
OBJECTIVE: Kinetic (very rapid) vitrification (K-VF) is a promising
approach for cryopreservation (CP) of biological materials as it is simple,
robust, and can achieve VF for practically any type of cells (Katkov et al,
2012).
DESIGN: Several methods of superfast K-VF, particularly for CP of oo-
cytes, embryos, sperm and human embryonic stem cells have been proposed
but practically all of them either require very small (in range 0,5-10 mcl) size
of the sample or/and cannot avoid the Leidenfrost effect (LFE), which sub-
stantially impedes the rate of cooling.
MATERIALS AND METHODS: Here, we are reporting an entirely new
system for hyper-fast cooling of one-two order of magnitude larger samples
developed in CELLTRONIX, which we called ‘‘KrioBlast(TM)’’ that
completely eliminates LFE and a need of potentially toxic and osmotically
damaging vitrificants such asDMSOor PGused in the currentmethods ofVF.
RESULTS: The system allowed us to vitrify up to 4,000 mcl of 15% glyc-
erol solutions (used as a cooling rate marker), which theoretically corre-
sponds to the critical cooling rate up to 600,000 C/min (Warkentin et al,
2008) or even higher. Particular applications for CP of reproductive and
stem cells for reproductive and regeneration medicine, husbandry, and cryo-
preservation of wildlife genetic resources are discussed. Some promising
preliminary data of hyper-fast of human sperm and embryonic stem cells
are also presented.
CONCLUSION: The hyperfast method we proposed is scalable, auto-
mated, and robust to the human’s error. This approach can ‘‘unify’’ the equip-
ment, the acesssoirs, and the vitrifcation media in one platform. This
KrioBlast(TM) platform can be considered as a step toward the ‘‘Universal
Cryopreservation Protocol’’ that will largely benefit Assisted Reproductive
Technologies and Regenrative Medicine.
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VITRIFICATION OF OOCYTES IS USEFUL FOR FERTILITY
PRESERVATION IN COUPLE OF NON-OBSTRUCTIVE AZOO-FERTILITY & STERILITYSPERMIA PATIENTS. E. K. Kim, E. A. Kim, J. H. Kim, H. Kwon,
J. E. Shin, D. H. Choi. Fertility Center, CHA Bundang Medical Center,
CHA University, Seongnam-si, Gyeonggi-do, Republic of Korea.
OBJECTIVE:Oocyte vitrificationmethod has been improved over the past
decade. The couples with severe male infertility are insufficient for fertiliza-
tion of retrieved oocytes, and especially the couples suffered from non-
obstructive azoospermia could not possible to fertilize with retrieved oocytes
in IVF. In that case, vitrification of oocytes could be an effective method for
future reference.The aim of this study is to find the outcomes of vitrified oo-
cytes using donor sperm.
DESIGN: Retrospective study.
MATERIALS AND METHODS: Between Jan. 2009 and Dec. 2012,
frozen oocytes from 6 patients of total 16 patients were thawed. And R
41yrs. andR4 cycles were excluded. Vitrification-thawed methods are fol-
lowed our previous study, vol. 90 supl. Sep. 2008 S282: F&S.
RESULTS: Clinical results are as follows.Clinical Results.No.of patients 6
Age(M SD)(yrs.) 29.22.8
Infertility duration(M SD) 3.12.0
No. of retrieved oocytes(M SD) 12.94.8
No. of vitrified oocytes(M SD) 89(12.75.0)
No. of survived oocytes(%) 85/89(95.5)
No. of 2PN(%) 65/80(81.3)
No. of embryos(%) 60/65(92.3)
No. of transferred embryos(M SD) 24(3.41.0)
Pregnancy rate(%) 2/6(33.3)CONCLUSION: Vitrification has been applied to human oocyte cryo-
preservation successfully so far. Furthermore this can induce more
effective results in severe male factor like non-obstructive azoospermia
in IVF.P-120 Tuesday, October 15, 2013
TRANSFER OF DAY-3 EMBRYOS IN THE FRESH CYCLE AND
SURPLUS BLASTOCYST IN THE THAWING CYCLE: ITS SUM-
MARY PREGNANCY CHANCE. F.-T. Kung, Y.-J. Lin, F.-J. Huang,
K.-C. Lan, P.-Y. Lin, H.-J. Chiang. OBGYN, Kaohsiung Chang Gung Me-
morial Hospital, Niao Sung District, Kaohsiung, Taiwan.
OBJECTIVE: To examine the pregnancy potential of thawing blastocysts
which were originally frozen on day 5 after extended culture of day-3 surplus
embryos in fresh cycles and to calculate the subsequent summary pregnancy
rate.
DESIGN: Prospective observational study.
MATERIALS AND METHODS: All of surplus embryos on the day 3 of
embryo transfer were kept cultured till day 5. Only the embryos able to
grow up to blastocyst stage were frozen by using vitrification method. Those
whose original fresh transfers were canceled with any reasons and who did
not return for transfer yet were excluded from the study. Endometrium was
prepared by clomiphene citrate stimulation or hormone replacement, or natu-
rally. The summary pregnancy rate was defined as the number of pregnancies
after transfer of sibling embryos both in fresh and thawing cycles divided by
the number of patients.
RESULTS: A total of 107 fresh cycles had available blastocysts for
freezing. Among them, 46 (43%) cycles in 46 patients had at least one
thawing embryo transfer. Originally, the clinical pregnancy and implanta-
tion rates were 28.3% and 13.7%, respectively, in those 46 fresh cycles.
Subsequently, 102 blastocysts were thawn and 99% of them survived. The
mean of storage tome was 9.5  10 months. Thirteen (28.3%) patients
succeeded in pregnancies with an implantation rate 14.8%. There were
no differences between success and failure in pregnancy groups in age,
body mass index, embryo storage time, endometrial thickness and pre-
freezing blastocyst quality. The summary pregnancy rate up to now was
56.5%.S181
